Cerebral toxoplasmosis in patient with relapsing-remitting multiple sclerosis under treatment with alemtuzumab

被引：3
|
作者：
Raquel, Calle-Calle [1 ]
Lucia, Triguero-Cueva [1 ]
Carmen, Valderrama-Martin [1 ]
Ana, Romero-Villarrubia [1 ]
Antonio, Tapia-Gomez [2 ]
Juan, Pasquau-Liano [2 ]
Carmen, Arnal-Garcia [1 ]
机构：
[1] Univ Hosp Granada, Dept Neurol Virgen Nieves, Granada, Spain
[2] Univ Hosp Granada, Unit Infect Dis Virgen Nieves, Granada, Spain
来源：
MULTIPLE SCLEROSIS AND RELATED DISORDERS | 2020年 / 39卷
关键词：
Alemtuzumab; Multiple sclerosis; Toxoplasmosis;
D O I：
10.1016/j.msard.2019.101885
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Alemtuzumab for the treatment of relapsing-remitting multiple sclerosis: a review of its clinical pharmacology, efficacy and safety
    Jones, David E.
    Goldman, Myla D.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2014, 10 (10) : 1281 - 1291
  • [42] Repopulation of T, B, and NK cells following alemtuzumab treatment in relapsing-remitting multiple sclerosis
    Gilmore, Wendy
    Lund, Brett T.
    Li, Peili
    Levy, Alex M.
    Kelland, Eve E.
    Akbari, Omid
    Groshen, Susan
    Cen, Steven Yong
    Pelletier, Daniel
    Weiner, Leslie P.
    Javed, Adil
    Dunn, Jeffrey E.
    Traboulsee, Anthony L.
    JOURNAL OF NEUROINFLAMMATION, 2020, 17 (01)
  • [43] Effectiveness and safety of alemtuzumab in the treatment of active relapsing-remitting multiple sclerosis: a multicenter, observational study
    Brecl Jakob, Gregor
    Barun, Barbara
    Gomezelj, Sarah
    Gabelic, Tereza
    Sega Jazbec, Sasa
    Adamec, Ivan
    Horvat Ledinek, Alenka
    Rot, Uros
    Krbot Skoric, Magdalena
    Habek, Mario
    NEUROLOGICAL SCIENCES, 2021, 42 (11) : 4591 - 4597
  • [44] Acute pneumonitis and pericarditis related to alemtuzumab therapy in relapsing-remitting multiple sclerosis
    María Rosario Blasco
    Antonio Ramos
    Celia García Malo
    Antonio García-Merino
    Journal of Neurology, 2017, 264 : 168 - 169
  • [45] Alemtuzumab-Related thyroid dysfunction in patients with relapsing-remitting Multiple Sclerosis
    Shaamile, F.
    O'Connor, A.
    McQuaid, S. E.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2019, 188 : S248 - S248
  • [46] Coagulation Activation And Cerebral Hypoperfusion In Relapsing-remitting Multiple Sclerosis
    Koudriavtseva, T.
    Zannino, S.
    Filippi, M.
    Cortese, A.
    Piantadosi, C.
    Villani, V.
    Lapucci, C.
    Fiorelli, M.
    Giannarelli, D.
    Stefanile, A.
    D'Agosto, G.
    Mandoj, C.
    Conti, L.
    Pimpinelli, F.
    Salvetti, M.
    Inglese, M.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (1_SUPPL) : 18 - 18
  • [47] Coagulation activation and cerebral hypoperfusion in relapsing-remitting multiple sclerosis
    Inglese, M.
    Zannino, S.
    Filippi, M. M.
    Cortese, A.
    Fiorelli, M.
    Lapucci, C.
    Piantadosi, C.
    Giannarelli, D.
    Mandoj, C.
    Stefanile, A.
    Conti, L.
    Salvetti, M.
    Koudriavtseva, T.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 850 - 851
  • [48] Alemtuzumab versus interferon beta 1a for relapsing-remitting multiple sclerosis
    Zhang, Jian
    Shi, Shengliang
    Zhang, Yueling
    Luo, Jiefeng
    Xiao, Yousheng
    Meng, Lian
    Yang, Xiaobo
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (11):
  • [49] BUDGET IMPACT MODELLING FOR ALEMTUZUMAB IN RELAPSING-REMITTING MULTIPLE SCLEROSIS PATIENTS IN COLOMBIA
    Londono, S.
    Gomez, N.
    VALUE IN HEALTH, 2020, 23 : S625 - S625
  • [50] Acute pneumonitis and pericarditis related to alemtuzumab therapy in relapsing-remitting multiple sclerosis
    Rosario Blasco, Maria
    Ramos, Antonio
    Garcia Malo, Celia
    Garcia-Merino, Antonio
    JOURNAL OF NEUROLOGY, 2017, 264 (01) : 168 - 169
12345